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ABSTRACT
The Aim of this study is to access the number of inappropriate usages of post CABG
antibiotics such as, Carbapenems, Teicoplanin and Linezolid in Shahid Rajaie Hospital and to
apply antibiotic practice guidelines and strategies to reduce inadequate treatment while determining
their impact on patient outcomes. This retrospective study was performed at special wards of
Shahid Rajaie Hospital. The program was conducted since March to August 2015. All of the
patients which were on Imipenem, Meropenem, Linezolide or Teicoplanin as an empiric treatment
or based on  culture results were considered in the study. The results of this study indicated that
among 136 in-patients who had taken at least one of these antibiotics including Imipenem,
Meropenem, Linezolide or Teicoplanin, antimicrobial prescription assumed inappropriate for 63
patients (46.32%), The most common reason was incorrect dosage (16.39%)and the least  one
was not being drug of choice(2.4%).this inappropriateness was occurred mostly in diagnosis of
respiratory infection, skin infection and sepsis. The results of this study demonstrates  the need
for revision in program of prescribing antibiotics in the direction of using antibiotic practice guidelines
especially regarding usage of Teicoplanin and Meropenem in specific complication such as
respiratory infection and  skin infection.
Key word: Carbapenems, Linezolid, Teicoplanin, Utilization, Evaluation.
INTRODUCTION
Drug Utilization Evaluation (DUE) studies
are designed to evaluate appropriate drug usage1.
These evaluations have been mostly focused on
drugs with narrow therapeutic index, high
consumption rate and price, and also broad
spectrum antibiotics such as Carbapenems,
Linezolid and Teicoplanin2. In these evaluations,
after identification of drug usage problems,
interventions are implemented to improve the
defects. New data need to be collected to determine
if the identified drug use has been improved as a
result of intervention then these finding  will be
available to the hospital staff3-4.
Irrational use of antibiotics has been a
global concern. Especially in developing countries5,
numerous studies reported the inappropriateness
use of 41-91% of all antibiotic prescriptions in
teaching hospitals6. The factors that physicians
should consider in selecting appropriate antibiotics
include proper detecting source of infection,
implementation of microbiological culture for
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definitive treatment, having enough information
regarding  antibiotics spectrum of actions,
considering antibiotic with reasonable price in
duration of therapy , considering host features and
possible complication caused by antibiotics7. It is
considerable to inform health care provider about
antimicrobial stewardship for more cooperation8.
Prophylaxis or overuse of broad spectrum
antibiotics may contribute to the emergence of
bacterial drug resistance9. Increased antimicrobial
resistance could be responsible for severe
infections which doesn’t respond effectively to the
antibiotics, complications, and increased length of
hospital stays and  mortality10. Several strategies
have been presented  to improve rational antibiotic
usage in the hospitals,These include a restricted
drug program, stop orders plan , antibiotic order
forms, antibiotic therapy based on guidelines,and
drug utilization evaluation11,12.
In this study, drug utilization was evaluated
based on patients’ medical records with an objective
to assess appropriate usage of critical antibiotics
such as Carbapenems, Linezolid and Teicoplanin
which have been identified as the last resort drugs.
The other objective of this study was to identify
prescriptions errors and to help reduce these errors.
MATERIAL AND METHOD
This retrospective study was performed at
special wards of Shahid Rajaie Hospital, Tehran,
Iran. The program was conducted from March to
August 2015. Post CABG adults older than 18 years
in five different units including one ICU and four
CCUs were included in this study. The selection of
patients were according to their treatment with
Imipenem, Meropenem,  Linezolide or Teicoplanin
as an empiric treatment or based on culture results.
Ertapenem dosenot evaluated in this study. Patients
who were identified to have allergy to studied
medications, psychiatric illness, history of seizure,
ClCr<20, pregnant and patients taking MAOI were
excluded from this study. DUE forms were designed
considering number of ordered and prescribed
antibiotics, dosage and frequency of administration,
indication for each antibiotic based on Mandell and
IDSA and CDC guidelines and information about
the patients such as serum creatinine,smoking,past
medication history about studied antibiotics,past
medical history such as heart or kidney disease.
Medical records of patients investigated and
necessary information were extracted.and some
parameter such as ClCr calculated. Appropriate or
inappropriate antibiotic prescriptions were
evaluated according to factors such as dosage or
duration (separately or combined), dosage
adjustment in patients with renal impairment,
antibiotic choice and indication. Descriptive
analyses of clinical data were performed using
SPSS statistical analysis software 20.
RESULTS
A total of 136 in-patients were evaluated
during a five month study,.demographic
characterization of patients include general
information , medical history ,antibiotic history
,duration of therapy and serum creatinine, has been
presented in Table 1. 66.9%of population are males
.almost half of patients had history of heart
disease(46.32%).These patients were hospitalized
at five special wards and they had taken at least
one of the antibiotics including Imipenem,
Meropenem, Linezolid or Teicoplanin . In this study,
14 patients who had known antibiotics usage
indications were considered despite lack of
sufficient data on dosage and duration of
prescriptions.
The usage frequency and amount of
studied antibiotics according to duration of
treatment among 122 patients with sufficient data
about prescribing state ,are shown in Table 2. These
data demonstrate that Meropenem with 1028
consumed vial was the most frequent antibiotic used
among the patients compared to the other
antibiotics such as Imipenem, Teicoplanin and
Linezolid which are ranked in the following places.
The ratio of prescribed daily dose to DDD was also
calculated according to Anatomic and therapeutic
chemical classification system (ATC/DDD). Defined
Daily Dose is the average maintenance dose of a
drug used in a day as its main indication. Lower
amount of prescribed daily dose to DDD can be
seen obviously that means insufficient usage in all
antibiotics.
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Table 1: Demographic information
Variables(N=136) Results
Gender(M/F) 91/45
Mean Age±SD(years) 55.51±9
Mean Weight SD(kg) 65.2±11.1
Duration of Imipenem therapy 6.67±4.07
Duration of Meropenem therapy 9.37±7.38
Duration of Linezolid therapy 8.8±4.3
Duration of Teicoplanin therapy 7.84±4.6
Serum creatinine 1.67 ± 1.58
Smoking and Addiction 45(33.08%)
History of heart disease 63(46.32%)
History of MI 9(6.61%)
History of embolism 18(13.23%)
History of Dibetes mellitus 14(10.29%)
History of kidney disease 16(11.76%)
COPD 4(2.94%)
History of Carbapenems, linezolid
or Teicoplanin exposure in hospital
in past 3months 37(27.2%)
Death/Alive 62/74
Table 2: Frequency of antibiotics usage
Antibiotics Usage duration of Number of Mean number miligram Prescribed
frequency*  Reatment Patients consumvial/ daily
(days) (percentage) patient /day dose/DDD**
Imipenem 449 6.67±4.07 22(18.03) 20.4 1529.9 0.76
Meropenem 1028 9.37±7.38 62(50.8) 16.58 1769.5 0.88
Linezolid 198 8.8±4.3 12(9.8) 16.5 1125 0.93
Teicoplanin 201 7.84±4.6 26(21.3) 7.7 394.4 0.98
* Considered vials of Imipenem 500 mg, Meropenem 1 gr ,Linezolid 0.6gr and Teicoplanin 0.4gr
 **DDD for Imipenem:2gr, Meropenem:2gr, Linezolid:1.2gr,Teicoplanin:0.4gr
Table 3: Prescription error reasons
Causes Imipenem% Meropenem% Linezolid% Teicoplanin% Total%
Antibiotics (n=22) (n=62) (n=12) (n=26) (n=122)
Appropriate prescription 68.18 41.9 66.7 38.46 48.36
Dosage and duration 13.6 12.9 - 7.69 10.65
Only Dosage 4.5 20.9 16.7 15.38 16.39
Only Duration 9.09 14.51 8.3 19.23 13.93
Dose adjustment in renal impairment 4.5 3.2 - 19.23 6.55
Indication - 6.45 8.3 - 4.09
Choice 13.6 - - - 2.4
P=0.01
Data presented in Table 3 shows that
almost half of the drugs prescribed appropriately
(n=59, 48.36%) while the rest of them were
prescribed inappropriately (n=63, 51.63%) which
means rate of consistency with reliable guidelines
in each aspect of prescribing mentioned in this table.
These data does not include the 14 patients with
insufficient data on their method of prescription
(n=14, 10.29%).There are significant differences
in reasons of inappropriateness (p<0.05).The most
common reason of inappropriate prescribing was
improper dosage (n=20, 16.39%) which is more
frequent in Meropenem (n=13,20.9%) compared
to other antibiotics. Data also showed higher level
of inappropriateness in duration of therapy
individually (n=17, 13.93%)compared to dosage
and duration of therapy together (n=13, 10.65%).
Unreasonable dosing  were identified in patients
with renal insufficiency (n=8, 6.55%), mostly due to
Teicoplanin (n=5.19.23%).Other reasons were
incorrect  drug choice (n=3, 2.4%) which is true
only about imipenem(n=3,13.6%) and  incorrect
indication (n=5, 4.09%) .This table also includes
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Table 4:  The comparison of antibiotic prescribing in different wards
Wards Number of patients Appropriate % Inappropriate% Insufficient data %
ICU-A 33 39.39 51.51 9.09
CCU-B 23 52.17 43.47 4.34
CCU-C 22 54.54 45.45 -
CCU-F 45 37.7 53.33 8.8
PCCU-A 13 38.46 15.38 46.15
P=0.176
Table 5: Antibiotics usage overview
Antibiotics Appropriate Inappropriate Insufficient Total  consumption
% % data % %(n=136)
Imipenem(n=24) 62.5 41.6 8.3 17.64
Meropenem(n=70) 37.14 51.42 11.42 51.47
Linezolid(n=13) 61.53 30.76 7.69 9.55
Teicoplanin(n=29) 34.48 55.17 10.34 21.32
P=0.542
Table 6: Antibiotics  Inappropriateness  rate according to  pathogenesis
Pathogenesis Imipenem Meropenem Linezolid Teicoplanin Total in
Antibiotics % (n=24)  %(n=70) %(n=13) %(n=29)  appropriateness
%(n=136)
Respiratory infection 16.6 18.57 7.69 20.68 17.64
Abdominal related infection* - 1.42 - 3.44 1.47
Skin infection - 7.14 - 13.79 6.61
Sepsis 4.16 10 7.69 10.34 8.82
Abscess 4.16 1.42 - - 2.2
Urinary tract infection 4.16 4.28 - - 2.94
Chest related infection ** - 4.28 7.69 3.44 3.67
Prophylaxis - 2.85 - - 1.47
Neutropenic fever - - - 3.44 0.73
Phlebitis - - 7.69 - 0.73
*Abdominal infection includes: pancreatitis and cholesystitis
**Chest infection includes: endocarditits and mediastinitis
the percentage of studied antibiotics
inappropriateness in patients taking each drug.
Although there were not significant
differences between wards (p=0.176), data
presented in Table 4 shows that almost half of the
prescribing were inappropriate in all wards except
PCCU-A (n=2,15.38%) which is likely due to few
investigated patients. The most common
inappropriate prescribing were observed in CCU-
F (n=24, 53.33%) followed by ICU-A (n=17,
51.51%).
Overall condition of antibiotics prescribing
can be seen in Table 5.meropenem has the  most
consumption among other antibiotics, this
nessecitates more attention to be paid to its
usage.There were not any significant differences
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among 4 studied antibiotics regarding
inappropriateness (p=0.542), whereas it can be
seen that the most inappropriate prescribing
belongs to Teicoplanin (n=16,55.17%), followed by
Meropenem (n=36,51.42%), Imipenem
(n=10,41.6%) and Linezolid (n=4,30.76%) in the
order of significance. It should be noted that
evaluating  guidelines adherence are  based on
number of errors rather than number of patients.
Data in table 6 shows that among 136
patients, the majority of inappropriateness for
Imipenem, Meropenem, Teicoplanin, were
observed in respiratory infection indication, while
sepsis, abscess and UTI with equal percentages
(4.16%) ,considered as the second place for
Imipenem. Moreover Sepsis and skin infection held
the second place for Meropenem and Teicoplanin,
respectively For Linezolid, inappropriateness
relates to diagnosis of respiratory infection, sepsis,
chest infection (mediastinitis) and phlebitis with
equal percentages (7.69%).Overall, incorrect
prescribing concerns are mostly in diagnosis of
respiratory infection (n=24, 17.64%), sepsis (n=12,
8.82%) and skin Infection (n=9, 6.61%) which have
the most inconsistency with guidelines.
On the other hand the low rates of
inappropriateness in Prophylaxis (n=2,1.47%) ,
Neutropenic fever (n=1,0.73%)and Phlebitis
(n=1,0.73%) were due to limited prescribing in
these indications.
Table 7: Antibiotics usage according to pathogenesis
Pathogenesis Appropria- Inappropria- Insufficient Total
Appropriateness  teness% teness% data % consumption
%(n=136)
Respiratory infection(n=51) 47.05 47.05 5.88 37.5
Abdominal related infection * (n=11) 45.45 18.18 36.36 8.08
Skin infection(n=21) 47.61 42.85 9.52 15.44
Sepsis(n=18) 27.7 66.6 5.55 13.23
Abscess(n=3) - 100 - 2.2
Urinary tract infection(n=15) 60 26.6 13.3 11.02
Chest related infection **  (n=7) 28.57 71.42 - 5.14
Prophylaxis(n=2) - 100 - 1.47
Neutropenic fever(n=5) 60 20 20 3.67
Phlebitis(n=3) 33.3 33.3 33.3 2.2
*Abdominal infection in appropriate prescribing includes pancreatic and ascites; for inappropriate prescribing includes
cholecystitis and pancreatitis
 **Chest infection includes mediastinitis and endocarditis
Table 7 shows prescribing condition of
studied antibiotics,and distribution of total
consumption of them in each infections .These
antibiotics mostly prescribed in Respiratory
infection (n=51,37.5%) with  an equal percentage
of adherenece and negligence to guidelines.
(47.05%) While usage of mentioned antibiotics in
the prophylaxis was rare (n=2, 1.47%).
On the other hand ,consumption of
antibiotics in abscess (n=3,100%),and prophylaxis
(n=2,100%),had complete inconsistency with
guidelines.This may be due to less prescribing in
these indication. As well among 18 patients who
took antibiotics for diagnosis of sepsis, most of
prescribing  was not according to  guidelines
(n=12,66.6%) this is also true about 5 out of 7
patients with mediastinitis Or endocarditis
(n=5,71.42%).
DISCUSSION
The aim of this study is evaluating the way
of prescribing of restricted and broad spectrum
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antibiotics such as Meropenem, Imipenem,
Linezolid and Teicoplanin according to standard
guidelines, and detecting fields of
inappropriateness to help health care providers
where to focus and therefore  reducing the rapid
emergence of resistant bacteria. Epidemiological
studies have revealed that there was correlation
between antibiotic consumption and emergence
and spreading of resistant bacteria strains13,14.
Antimicrobial stewardship programs (ASPs) has
important role in eradicating resistance strains15.
In our study rate of  inappropriate prescribing
regarding Imipenem (n=10,41.6%) has been due
to lack of consistency with antibiotics usage
guidelines in selecting appropriate antibiotic and
both dosage and duration of therapy (13.6%).On
the other hand Meropenem wrong dosage (20.9%)
is responsible for most unreasonable prescribing
of this drug (n=36,51.42%). The most cases suffer
from respiratory infections.
In a study conducted in Imam Hossein
Hospital, in Tehran ,the rate of irrational use of
Meropenem (59.3%)and Imipenem(53.4%) were
similar to our study ,however inaccuracy is mostly
due to unnecessary using of these antibiotics.
Although this study uses the same guidelines(IDSA
and Mandell),percentages of all causes of
inappropriateness had not been mentioned
distinctly as our study16.
In Amir Hospital,in Zabol ,rate of imipenem
inconsistency with indications that has been
mentioned in   AHFS guideline (92 %) was higher
than all causes of inconsistency in our study
(41.6%). Similar to our results,  most frequent
diagnosis for imipenem was pneumonia
administered 1540mg/day in 8.08 ± 4.67days,which
is near to our calculating (1529.9mg/day in
6.67±4.07days).
Compared to low rate of wrong imipenem
dose adjustment in our studied renal patients
(4.5%), there was 16% dosing error in this group of
patients in Zabol Hospital17. It can concluded that
imipenem prescribing state in Rajaei Hospital is
better than Zabol Hospital.
DUE which  has been done in Shariati
hospital in Tehran, demonstrates that 28% of
critically ill patients have  consumed inappropriate
dose of carbapenems in CNS infections and
menegitis, according to empric or culture based
treatment2. This rate is lower than our results about
carbapenems inappropriateness (48.93%)among
patients taking Imipenem and Meropenem
.Differences compared to our study were; fewer
evaluated wards (3ICUs), extended duration of
study (1year) , type of study and studied population.
In 3 months assessment of carbapenems utilization
conducted in  Abbotsford Regional Hospital, British
Columbia, reveals that the rate of inappropriateness
in empiric therapy of carbapenems is almost the
same as our results (37%) mostly due to prescribing
carbapenems without obvious infections.
Meropenem most commonly used compared to
other carbapenems.(85%).(18) As the same as our
results that meropenem had  higher rate of
utilization (n=70.51.47%).Ertapenem has not been
evaluated in our study despite of mentioned study.
Moreover meropenem had the second
place in irrational usage (51.42%) after
Teicoplanin(55.17%) mostly due to lack of
consistency with available guidelines in
dosage(20.9%)and duration of therapy
(14.51%).Inattention to guideline indications had
low rate (6.45%).Results extracted from Khan MU
et al study which have evaluated meropenem
utilization in teaching based hospital in Pakistan
shows that meropenem usage as empirical therapy
in 57%of cases was the major problem,whereas
most adherence to the standard guideline was
related to indication (97.52%) which is higher than
our results19. This study only evaluated meropenem
with more attention to side effects of this drug on
renal patients, also population and used guidelines
differ from our study.
Evaluation of  prescribing in our survey
was  based on frequency and amount of each
antibiotic in duration of therapy.According to
diagnosis and renal condition of Post CABG
patients  in special wards , there were different
variables ,groups of patients and wards which  has
not been investigated like this in the past ,but we
could not  estimate the rate of emprical or according
to culture treatment.
Linezolid has the least common antibiotic
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usage (n=13,9.55%) and the least
inappropriateness (30.76%) among four studied
antibiotics, mostly due to the lack of consistency
with available guidelines in dosage (16.7%) and in
diagnosis of respiratory infection,sepsis,chest
infection(mediastinitis )and phlebitis with equal
percentages (7.69%).
In study which was done in selected
Canadian provinces by Walker S et al, linezolid
has been prescribed  appropriately in
approximately 50% of 95 patients , most commonly
in Skin and soft tissue infections (32%)20.The
difference of this study is focusing in linezolid
appropriateness but our study evaluated
inappropriateness and their reasons. Certain
comments about linezolid  prescribing state was
not possible due to few number of studied patients.
Most inappropriateness was seen in
teicoplanin with 55.17% irrational usage mostly due
to  error in both dose adjustment in renal patients
and duration of antibiotic treatment(19.2%) in
pneumonia pathogenesis.These results can be
compared with Hamishehkar et al study ,which
teicoplanin consumption considered irrational in
febrile neutropenic cancer patients due to
unnecessary utilization in patients without renal
impairment(47%)21.The mean number of vials
consumed  per patient for meropenem and
teicoplanin was the same (16.5) considering vial1gr
for meropenem in 9.377.38 duration of treatment
and vial 400 mg for teicoplanin in 7.844.6 duration
of treatment, which is higher than mean number of
200mg vials of teicoplanin consumed per patient
had been evaluated in the hospital at  spain ( 30.8)
in longer period of treatment(13.94 ± 10.82 ) used
for gram-positive infections22. The results of this
study demonstrated higher teicoplanin cost of
therapy compared to vancomycin.As in Iran  higher
price of teicoplanin makes vancomycin more cost
effective21. Utilization of more amount of teicoplanin
in lower duration of treatment can be  the reason of
microbial resistance outbreak23. On the other hand
the most errors in renal dose adjustment among
four studied antibiotics belong to teicoplanin
therefore we can conclude that strict policies and
strategies need to be implemented for teicoplanin
use and dose adjustment  specially in renal
impairment patients according to standard
guidelines.
CONCLUSION
Drug Utilization Evaluation (DUE) was
found to be an effective approach to identify
inappropriate prescribing and to improve rational
use of antibiotics. Consumption of broad spectrum
antibiotics especially meropenem should be
restricted in dosage and duration and also it should
be justified according to guidelines. Most
inconsistency regarding teicoplanin was in renal
dosage adjustment and this issue needs ASPs.
Although linezolid had lowest degree of
consumption and incorrect prescribing, usage of
this drug should be with caution due to its special
place as the last resort antibiotics.
More inadherence to guidelines  were
observed in respiratory infection, sepsis and  skin
infection .Based on these observations, it is
advisable to use antibiotics with adherence to
standard guidelines  and microbiology culture after
empiric therapy.
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